| Market Commentary | Thursday, June 01, 2006 09:49 Hrs IST |
|
STOCK ALERT Sterlite Industries may gain on strong Q4 outcome
Sterlite Industries has reported a profit after tax before extra-ordinary items of Rs 240.71 crore for Q4 March 2006 as compared Rs 86.60 crore for Q4 March 2005. Net sales has risen 117.8% to Rs 2515.40 crore (Rs 1154.62 crore). Bhel has reported a net profit of Rs 867.95 crore for Q4 March 2006 as compared to a net profit of Rs 584.63 crore for Q4 March 2005. Net sales has risen to Rs 5515.69 crore from Rs 4466.61 crore. EIH has reported a net profit of Rs 37.33 crore for Q4 March 2006 as compared to a net profit of Rs 20.78 crore for Q4 March 2005. Net sales has risen to Rs 227.10 crore from Rs 176.58 crore. The company’s board recommended a 1:2 bonus issue and 5-for-1 stock split. Five stocks Reliance Capital, Bajaj Hindustan, Jaiprakash Associates, Indiabulls and Siemens enter Morgan Stanley Capital International standard index series starting today. All these five stocks staged an intra-day rebound on Wednesday 31 May ahead of their inclusion. The lone exclusion from the index is Castrol. Hero Honda Motors said on Thursday it sold 3,03,000 units in May 2006. Sales in corresponding period last month were not available. The board of NTPC has approved the proposal to take over Government of India owned Badarpur Thermal Power Station (BTPS) pursuant to the decision of the Government to transfer power business of BTPS to NTPC. Following the transfer of BTPS to NTPC, NTPC’s installed capacity will go up to from 23,935 MW to 24,640 MW. Dr Reddy’s Lab reported a net loss of Rs 23.60 crore in Q4 March 2006 compared to a net loss of Rs 51.90 crore in Q4 March 2005. The loss in Q4 March 2006 was because of weak gross margins from its international operations such as Mexico and UK. Revenues, which were pressured the previous year by changes to the tax system, rose 64% to Rs 690 crore from Rs 420 crore. The latest quarter revenues include 28 days of revenue from Germany's Betapharm and its active pharmaceutical ingredients business in Mexico which it bought from Roche
|
|
|||||||||||||||||||||
|
|
|||||||||||||||||||||||